Anda di halaman 1dari 2

Besiintravenapasaribu_m

DAFTAR PUSTAKA
1. Bakta IM. Pendekatan terhadap pasien anemia. Dalam: Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S, penyunting. Buku Ajar Ilmu Penyakit Dalam. Edisi V. Jakarta Pusat: Interna Publishing; 2011. h.1109-15. 2. Benoist B, McLean E, Egli I, Cogswell M. Worldwide prevalence of anaemia 1993-2005. Switzerland: WHO press; 2008. 3. Bakta IM. Hematologi klinik. Jakarta: EGC; 2007. h.26-39. 4. WHO 2004, http://www.who.int/nut/ida.htm 5. Isniati, Efek suplementasi Tablet Fe + Obat Cacing terhadap kadar hemoglobin remaja yang anemia di pondok pesantren tarbiyah islamiyah tahun 2008, J. Sains Tek. Far. 12 (2) 2007.
6.

Beutler E. Disorders of iron metabolism. In: Lichtman MA, Williams WJ, Beutler E, et al. (eds), Williams Hematology, 7th ed. New York: McGraw-Hill, 2006. Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. Gut. 2000;46(Suppl IV):iv1-iv5. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol. 2005;18:319-332. Fishbane S, Pollack S, Feldman HI, Joffe MM. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004. Clin J Am Soc Nephrol. 2009;4:57-61. AL, Penney MD, Allison MC. The prevalence of iron deficiency among patients presenting with colorectal cancer. Colorectal Dis. 2005;7:398-402. M, Dalla Mola A, Carnia L, et al. Saving costs in cancer anemia management. Recognizing functional iron deficiency (FID) and rationalizing EPO therapy. Proc Am Soc Clin Oncol. 2002;21:Abstract 2828 TC, Li H, Rose MJ, Wang O, Sasu BJ. Evaluation of serum hepcidin concentrations in cancer and leukemia patients. J Clin Oncol. 2008;26(Suppl 15 S):20581. Abstract O, Adamsky K, Margalit O, et al. Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53. Br J Haematol. 2007;138:253-262. Y. Prediction of response to optimize outcome of treatment with erythropoietin. Semin Oncol. 1998;25:27-34.
11

7.

8.

9.

10. Beale

11. Galliano

12. Arvedson

13. Weizer-Stern

14. Beguin

Besiintravenapasaribu_m

15. Andrews

NC. Disorder 1999;341:1986-1995.

of

Iron

Metabolism,

Engl

Med.

16. Pak M, Lopez MA, et.al. Suppression of hepcidin during anemia requires erythropoietic activity, Blood, 2006, Vol. 108 (12)
17. Auerbach

M, Ballard H, Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety, American Society of Hematology 2010 18. Edward J, Benz Jr. Disorders of Hemoglobin. Dalam: Fauci AS, Braunwald E, penyunting. Harrisons principles of internal medicine. 17th ed. United states: The McGraw-Hill Companies; 2008. h.635-42

19. Chertow GM, Mason PD et. Al Update on adverse drug events associated with parenteral iron, Nephrol Dial Transplant ,2006, 21: 378382 20. Coyne DW et al. Kidney International 2003; 63: 217-224 21. Henry DH, SABM- abstract, school of Medicine, University of Pennsylvania, 2011 22. Breymann C, The Use of Iron Sucrose Complex for Anemia in Pregnancy and the Postpartum Period, 2006 Semin Hematol 43(suppl 6):S28-S31 23. Ragip Al, Eylem U et al, Intravenous Versus Oral Iron for Treatment of Anemia in Pregnancy: A Randomized Trial. Obstetrics & Gynecology. 106(6):1335-1340, December 2005. 24. Wazny, Lori D et.al. Raymond, Colette B. Iron replacement and supplementation in patients with chronic kidney disease. Canadian Association of Nephrology Nurses & Technologists 2011

12

Anda mungkin juga menyukai